Principal Securities’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-253
Closed -$33.8K 3043
2025
Q3
$33.8K Sell
253
-20
-7% -$2.43K ﹤0.01% 2150
2025
Q2
$34K Sell
273
-88
-24% -$11.2K ﹤0.01% 2062
2025
Q1
$52K Hold
361
﹤0.01% 1745
2024
Q4
$52K Buy
361
+8
+2% +$1.15K ﹤0.01% 1744
2024
Q3
$52.5K Buy
353
+75
+27% +$10.8K ﹤0.01% 1669
2024
Q2
$35K Sell
278
-2
-0.7% -$313 ﹤0.01% 1786
2024
Q1
$51.5K Buy
280
+11
+4% +$2.1K ﹤0.01% 1557
2023
Q4
$48.4K Buy
+269
New +$41.9K ﹤0.01% 1505

Other funds holding RGEN

Principal Securities's RGEN Position: Q4 2025 in Review

Principal Securities sold out of Repligen (RGEN) in Q4 2025, closing a stake of 253 shares — an estimated $33.8K sold.

Principal Securities first reported a position in RGEN in Q4 2023 and held it in 8 quarters. The position peaked at $52.5K in Q3 2024. 473 funds tracked by Wall St. Rank hold RGEN as of Q4 2025.

  • Principal Securities reported no remaining Repligen position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 253 Repligen shares in Q4 2025, an estimated $33.8K.
  • Principal Securities first reported a position in Repligen in Q4 2023 and held it in 8 quarters.
  • Principal Securities's Repligen position peaked at $52.5K in Q3 2024.
  • 473 funds tracked by Wall St. Rank held Repligen as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.